Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances

References

• Crago AM, Singer S. Clinical and molecular approaches to well-differentiated and dedifferentiated liposarcoma. Curr Opin Oncol 2011;23(4):373-8
   PubMed Web of Science ®Google Scholar
• Taylor BS, Barrentina J, Maki RG, et al. Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer 2011;11:541-57
   PubMed Web of Science ®Google Scholar
• Guo T, Chang NE, Singer S, et al. Consistent MYC and FLT4 amplification in radiation –induced angiosarcoma but not in other radiation associated atypical vascular lesions. Genes Chromosomes Cancer 2010;50:25-33
   Google Scholar
• Patil D, Rubin BP. Gastrointestinal stromal tumor. Advances in diagnosis and management. Arch Pathol Lab Med 2011;135:1298-310
   Google Scholar
• Antonescu CR. The GIST paradigm: lessons for other kinase-driven cancers. J Pathol 2010;223(2):251-61
   Google Scholar
• Cantile M, Marra L, Franco R, et al. Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors. Mol Oncol 2013;30:413-18
   Google Scholar
• Riggi N, Cironi L, Suvà ML, et al. Sarcomas Genetics, signaling and cellular origins. Part 1: The fellowship of TET. J Pathol 2007;213:4-20
   PubMed Web of Science ®Google Scholar
• Demicco EG. Sarcoma diagnosis in the age of molecular pathology. Adv Anat Pathol 2013;20(4):264-74
   PubMedGoogle Scholar
• Suvà ML, Cironi L, Riggi N, et al. Sarcomas: genetics, signaling and cellular origins. Part 2:TET-independent fusion proteins and receptor tyrosine kinase mutations. J Pathol 2007;213:117-30
   Google Scholar
• Errani C, Zhang L, Sung YS, et al. A novel WWTRI-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 2011;50:644-53
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Le Loarer F, Mosquera JM, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 2013;52:775-84
   PubMed Web of Science ®Google Scholar
• Pierron G, Tirode F, Lucchesi C, et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 2012;44(4):461-6
   PubMed Web of Science ®Google Scholar
• Italiano A, Sung YS, Zhang L, et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 2012;51:207-18
   PubMed Web of Science ®Google Scholar
• Mosquera JM, Sboner A, Zhang L, et al. Novel MIR153-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer 2013;52:1075-87
   Google Scholar
• Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors- a subgroup of small round cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9
   PubMed Web of Science ®Google Scholar
• Ginsberg JP, de Alava E, Ladanyi M, et al. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing’s sarcoma. J Clin Oncol 1999;17:1809-14
   PubMed Web of Science ®Google Scholar
• Jeon IS, Davis JN, Braun BS, et al. A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995;10:1229-34
   PubMed Web of Science ®Google Scholar
• Sankar S, Lessnick SL. Promiscuous partnerships in Ewing sarcoma. Cancer Genet 2011;204:351-65
   PubMed Web of Science ®Google Scholar
• Brennan MF, Antonescu CR, Maki RG. Management of soft tissue sarcoma. Springer; New York, NY, USA: 2013
   Google Scholar
• Kawamura-Saito M, Yamazaki Y, Kaneko K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family of genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006;15:2125-37
   PubMed Web of Science ®Google Scholar
• Antonescu C. Round cell sarcomas beyond Ewing: emerging entities. Histopathology 2014;64:26-37
   Google Scholar
• Barr FG, Womer R. Rhabdomyosarcoma. In: Orkin SH, Fisher DE, Look AT, Lux SE, Ginsberg D, Nathan DG, editors. Oncology of infancy and childhood. Saunders; Philadelphia, PA, USA: 2009
   Google Scholar
• Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology group. J Clin Oncol 2002;20(11):2672-9
   PubMed Web of Science ®Google Scholar
• Barr FG, Smith LM, Lynch JC, et al. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trail: a report from the Children’s Oncology group. J Mol Diagn 2006;8(2):202-8
   PubMed Web of Science ®Google Scholar
• Sumegi J, Streblow R, Frayer RW, et al. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010;49(3):224-36
   PubMed Web of Science ®Google Scholar
• Meza JL, Anderson J, Pappo AS, et al. Analysis of prognostic Factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol 2006;24:3844-51
   PubMed Web of Science ®Google Scholar
• Williamson D, Missiaglia E, de Reyniés A, et al. Fusion gene-Negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010;28:2151-8
   PubMed Web of Science ®Google Scholar
• Parham D, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol 2013;20:387-97
   PubMed Web of Science ®Google Scholar
• Duan F, Smith LM, Gustafson DM, et al. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children’s Oncology Group. Genes Chromosomes Cancer 2012;51:662-74
   PubMed Web of Science ®Google Scholar
• Miettinen M. Modern soft tissue pathology: tumors and non-neoplastic conditions. 1st edition. Cambridge University Press; Cambridge, UK: 2010
   Google Scholar
• Antonescu C. Malignant vascular tumors-an update. Mod Pathol 2014;27:530-8
   Google Scholar
• Tanas MR, Sboner A, Oliveira AM, et al. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 2011;3(98):98ra82
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Chen L, et al. The HIPPO pathway in biological control and cancer development. J Cell Physiol 2011;226:928-39
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Guo K, et al. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem 2009;284:14347-58
   PubMed Web of Science ®Google Scholar
• Bouche N, Scharlat A, Snedden W, et al. A novel family of calmodulin-binding transcription activators in multicellular organisms. J Biol Chem 2002;277:21851-61
   PubMed Web of Science ®Google Scholar
• Errani C, Sung YS, Zhang L, et al. Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints. Cancer Genet 2012;205:12-17
   Google Scholar
• Ellis CL, Eble JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age and stage. Mod Pathol 2013;10:1-12
   Google Scholar
• Hodge JC, Pearce KE, Wang X, et al. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol 2014;1:113-27
   Google Scholar
• Argani P, Aulmann S, Illei PB, et al. A distinctive subset of PEComas harbors TFE3 Gene fusions. Am J Surg Pathol 2010;10:1395-406
   Google Scholar
• Fletcher CD, Bridge JA, Hogendoorn PC, Mertens F. WHO classification of tumours of soft tissue and bone. WHO Press; Switzerland: 2013
   Google Scholar
• Joyama S, Ueda T, Shimizu K, et al. Chromosomal rearrangement at 17q25 and xp11.2 in alveolar soft part sarcoma: a case report and review of the literature. Cancer 1999;86:1246-50
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Lui MY, Antonescu CR, et al. The der (17)t(X;11)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001;20:48-57
   PubMed Web of Science ®Google Scholar
• Dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 2001;30:1-14
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial Sarcoma. Cancer Genet Cytogenet 2002;133:1-33
   Google Scholar
• Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 2001;20:5755-62
   Web of Science ®Google Scholar
• Kadoch C, Cradtree GR. Reversible disruption of mSWI/SNF(BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell 2013;153(1):71-85
   PubMed Web of Science ®Google Scholar
• Maire G, Fraitag S, Galmiche L, et al. A clinical, histologic and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans. Arch Dermatol 2007;143:203-10
   Google Scholar
• Enzinger FM, Weiss SW. Fibrohistiocytic tumors of intermediate malignancy. In: Stamathis G, editor. Soft tissue tumors. Mosby; St. Louis, Missouri, USA: 2008
   Google Scholar
• Fisher C. Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch 2010;456:153-66
   Google Scholar
• Pedeutour F, Simon MP, Minoletti F, et al. Translocation t(17;22)(q22;q13) in dermatofibrosarcoma protuberans: a new tumor associated chromosome rearrangement. Cytogenet Cell Genet 1996;72:171-4
   PubMedGoogle Scholar
• Simon MP, Pedeutour F, Sirvent N, et al. Deregulation of the platelet –derived growth factor B-chain gene via fusion with collagen gene COLA1A1 in dermatofibrosarcoma protuberans and giant cell fibroblastoma. Nat Genet 1997;15:95-8
   PubMed Web of Science ®Google Scholar
• Nishio J, Iwassaki H, Ohijimi Y, et al. Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) may contain sequences from 8q11.2 qter and 17q21-qter: a combined cytogenetic and comparative genomic hybridization study. Cancer Genet Cytogenet 2001;129:102-6
   Google Scholar
• Sirvent N, Maire G, Pedeutour F, et al. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003;37:1-19
   PubMed Web of Science ®Google Scholar
• Walluks K, Chen Y, Woelfel C, et al. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans. Pathol Res Pract 2013;30-30:35
   Google Scholar
• Yoshida A, Tsuta K, Ohno M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014;38(4):552-9
   PubMed Web of Science ®Google Scholar
• Mentzel T, Bainbridge TC, Katenkamp D, et al. Solitary fibrous tumor: clinicopathological, immunohistochemical, and ultrastructural analysis of 12 cases in soft tissues, nasal cavity, and nasopharynx, urinary bladder and prostate. Virchows Archiv 1997;430:445-53
   PubMed Web of Science ®Google Scholar
• Furusato E, Valanzuela IA, Fanburg Smith JC, et al. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma and fibrous histiocytoma of the orbit reappraisal of 41 cases. Hum Pathol 2011;42:120-8
   PubMed Web of Science ®Google Scholar
• Mohajeri A, Tayebwa J, Collin A, et al. Comprehensive genetic analysis identifies a pathognomic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances and a characteristic gene expression profile in solitary fibrous tumor. Genes chromosomes Cancer 2013;52:873-86
   Google Scholar
• Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013;45:180-5
   PubMed Web of Science ®Google Scholar
• Barthelmeß S, Geddert H, Boltze C, et al. Solitary fibrous tumors/Hemangiopericytomas with different variants of NAB2-STAT6 fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 2014;184:1209-18
   PubMed Web of Science ®Google Scholar
• Malhotra B, Schuetze SM. Dermatofibrosarcoma Protuberans treatment with platelet derived growth factor receptor inhibitor: a review of clinical trial results. Curr Opin Oncol 2012;24:419-24
   PubMed Web of Science ®Google Scholar
• Olanich ME, Barr FG. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opin Theraup Targets 2013;17(5):607-23
   PubMed Web of Science ®Google Scholar
• Forscher C, Mita M, Figlin R. Targeted therapy for Sarcomas. Biologics 2014;8:91-105
   PubMedGoogle Scholar
• Ray-Coquard I, Montesco MC, Coindre JM, et al. Sarcoma: concordance between initial diagnosis and centralized expert review in a population bases study within three European regions. Ann Oncol 2012;23:24442-2449
   Google Scholar
• Janknecht R. EWS-ETS oncoproteins: the lichipin of Ewing tumors. Gene 2005;363:1-14
   PubMedGoogle Scholar
• Meyer C, Schneider B, Jakob S, et al. The MLL recombine of acute leukemias. Leukemia 2006;20:777-84
   PubMed Web of Science ®Google Scholar
• Bohlander SK. ETV6, a versatile player in leukemogenesis. Semin Cancer Biol 2005;15:162-74
   PubMed Web of Science ®Google Scholar
• Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev 2007;7:233-45
   Google Scholar
• Su Z, Ning B, Fang H, et al. Next-generation sequencing and its applications in molecular diagnostics. Expert Rev Mol Diagn 2011;11(3):333-43
   PubMed Web of Science ®Google Scholar